A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. The metric has seen a significant loss of -4.52% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -34.50%. Over the past 30 days, the price of TSHA has leaped by -17.56%. And in the last five days, it has fallen by -14.21%.
The market performance of Taysha Gene Therapies Inc has been somewhat unstable. Over the past year, the company’s stock achieved a high of $4.32 on 06/13/24, with the lowest value for the same timeframe being $1.27, recorded on 11/14/23.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
52-week price history of TSHA Stock
The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. Taysha Gene Therapies Inc’s current trading price is -60.88% away from its 52-week high, while its distance from the 52-week low is 33.07%. The stock’s price range for this period has been between $1.27 and $4.32. The Healthcare sector company’s shares saw a trading volume of about 2.09 million for the day, which was higher than the average daily volume of 1.53 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Taysha Gene Therapies Inc (TSHA) has experienced a quarterly decline of -19.52% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 346.35M and boasts a workforce of 52 employees.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 2.2600, with a change in price of -2.2300. Similarly, Taysha Gene Therapies Inc recorded 2,132,794 in trading volume during the last 100 days, posting a change of -56.89%.
TSHA’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for TSHA stands at 0.53. Similarly, the long-term debt-to-equity ratio is also 0.51.
TSHA Stock Stochastic Average
As of today, the raw stochastic average of Taysha Gene Therapies Inc over the last 50 days is at 1.48%. This shows a declinee from the raw stochastic average of the previous 20 days, which was recorded at 2.44%. Further, the company’s Stochastic %K and %D values for the last 20 days were 14.81% and 26.03%, respectively.
